Attenuation of the Hemodynamic Response to Double-lumen Endotracheal Intubation With Nebulized Lidocaine
Lung Neoplasms

About this trial
This is an interventional prevention trial for Lung Neoplasms focused on measuring Double-lumen Endotracheal Intubation
Eligibility Criteria
Inclusion Criteria: aged 18-65 years, American Society of Anesthesiologists class I-II participants undergoing double-lumen endotracheal intubation under general anesthesia signed informed consent and volunteered to participate in the experiment Exclusion Criteria: Poor control of hypertension preoperative arrhythmia severe coronary artery or heart valve disease sequelae of cerebrovascular accident severe lung, liver, kidney and immune system diseases Suspected difficult airway confirmed or suspected allergy to this trial drug As judged by the investigator to be ineligible for the study, such as communication impairment (language or intelligence)
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
lidocaine
saline
Intervention group
control group